abstract |
The present invention relates to controlled release pharmaceutical formulations of cholesteryl ester transfer protein inhibitors (CETPIs), methods of use and preparation thereof. In particular, the present invention relates to CETPI [2R, 4S] 4-[(3,5-bis-trifluoromethyl-benzyl) -methoxycarbonyl-amino] -2-ethyl-6-trifluoromethyl-3, It relates to a controlled release form of 4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester. |